Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 13
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
9/11/2007
1.
Phase II Chemotherapy with DHAC for Advanced Adult non-Small Cell Carcinoma of the Bronchus
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
CHNMC-IRB-4205
NCI-T84-0414D, T84-0414
2.
Phase II Chemotherapy with DHAC in Patients with non-Small Cell or Small Cell Bronchogenic Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
15 and over
NCI
MDA-DM-8466
NCI-T84-0494C, T84-0494
Last Modified:
10/1/1988
3.
Phase II Chemotherapy with DHAC in Patients with Metastatic Adenocarcinoma of the Colon (Summary Last Modified 10/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
over 18
NCI
OSU-84HO272
OSU-8507, NCI-T85-0008D, T85-0008
4.
Phase II Master Protocol for the Study of New Agents in the Treatment of Metastatic Adenocarcinoma of the Breast --- DHAC
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
ICC-86B1
NCI-T86-0076D, T86-0076
Last Modified:
5/1/1989
5.
Phase II Study of Dihydro-5-azacytidine in Patients with Malignant Mesothelioma (Summary Last Modified 05/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
15 to 80
NCI
MDA-DM-8654
NCI-T86-0154C, T86-0154
Last Modified:
5/1/1988
6.
Phase II Master Protocol for the Study of New Agents in Patients with Ovarian Carcinoma of Coelomic Epithelial Origin --- DHAC (Summary Last Modified 05/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 to 75
NCI
ICC-86G1
NCI-T86-0246D, T86-0246
Last Modified:
12/1/1991
7.
Phase II Study of Dihydro-5-azacytidine in Patients with Malignant Mesothelioma (Summary Last Modified 12/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
any age
NCI
SWOG-8842
Last Modified:
11/1/1991
8.
Phase II Chemotherapy with Dihydro-5-azacytidine in Patients with Advanced Malignant Melanoma (Summary Last Modified 11/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
MAYO-877007
NCI-T88-0024D, T88-0024
Last Modified:
7/5/2006
9.
Phase II Master Protocol for Chemotherapy in Patients with Malignant Mesothelioma --- Dihydro-5-Azacytidine
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
over 15
NCI
CLB-8833
CALGB-8833
Last Modified:
9/11/2007
10.
Phase II Master Protocol for Chemotherapy in Patients with Malignant Mesothelioma --- DHAC plus CDDP
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
over 15
NCI
CLB-9031
CALGB-9031
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute